Patient Guide: An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 10 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06836232
Status: 🟢 Enrolling Now
Condition: Recurrent Pericarditis
Phase: PHASE2

Where You Can Participate

This study is available at 10 locations across the country.

Top locations include:
  • • Tucson, Arizona
  • • Orange, California
  • • Saint Augustine, Florida
  • • And 7 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis - Join Clinical Trial NCTNCT06836232

How to Join This Clinical Trial - NCTNCT06836232

Learn how to participate in this PHASE2 trial studying an investigational therapy for Recurrent Pericarditis. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Recurrent Pericarditis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Recurrent Pericarditis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06836232 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 10 locations. Find a study site near you:

Clinical Research Site

Tucson, Arizona 85718 - United States

Status: RECRUITING

Clinical Research Site

Orange, California 92868 - United States

Status: RECRUITING

Clinical Research Site

Saint Augustine, Florida 32086 - United States

Status: RECRUITING

Clinical Research Site

Chicago, Illinois 60611 - United States

Status: RECRUITING

Clinical Research Site

Park Ridge, Illinois 60068 - United States

Status: RECRUITING

Clinical Research Site

Owensboro, Kentucky 42303 - United States

Status: WITHDRAWN

Clinical Research Site

Rochester, Minnesota 55905 - United States

Status: RECRUITING

Clinical Research Site

Houston, Texas 77034 - United States

Status: RECRUITING

Clinical Research Site

Salt Lake City, Utah 84132 - United States

Status: RECRUITING

Clinical Research Site

Richmond, Virginia 23219 - United States

Status: RECRUITING

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Recurrent Pericarditis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships